Kalvista Pharmaceuticals Inc (KALV.OQ)
KALV.OQ on NASDAQ Stock Exchange Global Market
11.88USD
18 Oct 2019
11.88USD
18 Oct 2019
Change (% chg)
$-0.18 (-1.49%)
$-0.18 (-1.49%)
Prev Close
$12.06
$12.06
Open
$11.96
$11.96
Day's High
$12.25
$12.25
Day's Low
$11.55
$11.55
Volume
97,316
97,316
Avg. Vol
53,760
53,760
52-wk High
$34.65
$34.65
52-wk Low
$10.04
$10.04
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2020 | Jul | 3.37 | -0.420 |
| FY 2019 | Apr '19 | 2.93 | -0.496 |
| Jan '19 | 3.89 | -0.230 | |
| Oct | 5.59 | -0.219 | |
| Jul | 3.72 | -0.466 | |
| FY 2018 | Apr '18 | 4.84 | -0.061 |
| Jan '18 | 2.33 | -0.485 | |
| Oct | 1.13 | -0.498 | |
| Jul | 0.10 | -0.507 | |
| FY 2017 | Apr '17 | 0.11 | -0.440 |
| Jan '17 | 0.25 | -0.998 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Apr-19 | 6 | 4.04 | 5.03 | 3.00 | -- |
| Quarter Ending Jul-20 | 1 | 4.12 | 4.12 | 4.12 | -- |
| Year Ending Apr-19 | 6 | 16.82 | 17.40 | 15.30 | -- |
| Year Ending Apr-20 | 7 | 30.99 | 73.10 | 12.40 | 20.82 |
| Year Ending Apr-21 | 7 | 26.92 | 140.10 | 0.00 | 10.00 |
| Earnings (per share) | |||||
| Quarter Ending Apr-19 | 5 | -0.35 | -0.28 | -0.44 | -- |
| Quarter Ending Jul-20 | 1 | -0.39 | -0.39 | -0.39 | -- |
| Year Ending Apr-19 | 5 | -1.33 | -1.18 | -1.68 | -- |
| Year Ending Apr-20 | 7 | -1.25 | 1.17 | -2.52 | -1.99 |
| Year Ending Apr-21 | 7 | -1.95 | 3.35 | -3.79 | -4.21 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 29.88 | 32.66 | |
| P/E High - Last 5 Yrs. | -- | 42.96 | 47.30 | |
| P/E Low - Last 5 Yrs. | -- | 23.36 | 23.87 | |
| Beta | -- | 0.89 | 0.89 | |
| Price to Sales (TTM) | 151.44 | 6.27 | 7.92 | |
| Price to Book (MRQ) | 2.63 | 5.26 | 5.38 | |
| Price to Tangible Book (MRQ) | 2.63 | 5.94 | 6.72 | |
| Price to Cash Flow (TTM) | -- | 23.50 | 24.36 | |
| % Owned Institutions | 80.82 | 0.76 | 1.46 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.42 | 1.35 | |
| Dividend Yield - 5 Year Avg | -- | 1.45 | 1.38 | |
| Dividend 5 Year Growth Rate | -- | 3.90 | 4.53 | |
| Payout Ratio(TTM) | -- | 42.58 | 40.23 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 1,271.43 | 5.12 | 12.22 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 1,503.45 | 6.49 | 7.74 | |
| Sales - 5 Yr. Growth Rate | -- | 10.58 | 10.87 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 87.02 | 40.57 | 42.96 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 75.80 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 9.78 | 10.31 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 15.43 | 14.84 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.11 | 2.20 |
| Current Ratio (MRQ) | 7.87 | 2.93 | 3.03 |
| LT Debt to Equity (MRQ) | 0.80 | 7.95 | 10.22 |
| Total Debt to Equity (MRQ) | 1.55 | 11.65 | 14.57 |
| Interest Coverage (TTM) | -29.72 | 33.53 | 29.79 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 51.83 | 52.20 | |
| Gross Margin - 5 Yr. Avg. | -- | 49.68 | 50.41 | |
| EBITD Margin (TTM) | -4,520.00 | -- | -- | |
| EBITD - 5 Yr. Avg | -- | 17.36 | 13.12 | |
| Operating Margin (TTM) | -4,529.25 | 13.64 | 6.77 | |
| Operating Margin - 5 Yr. Avg. | -- | 13.91 | 8.92 | |
| Pre-Tax Margin (TTM) | -4,120.21 | 12.26 | 5.95 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | 14.32 | 9.21 | |
| Net Profit Margin (TTM) | -4,120.21 | 9.05 | 2.59 | |
| Net Profit Margin - 5 Yr. Avg. | -- | 10.75 | 5.58 | |
| Effective Tax Rate (TTM) | -- | 22.44 | 22.41 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 22.49 | 22.75 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | -- | 992,493,005 | 886,862,481 | |
| Net Income/Employee (TTM) | -- | 113,962,481 | 101,795,790 | |
| Receivable Turnover (TTM) | -- | 5.96 | 5.96 | |
| Inventory Turnover (TTM) | -- | 2.62 | 3.36 | |
| Asset Turnover (TTM) | 0.01 | 0.97 | 0.94 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -55.70 | 11.50 | 11.12 | |
| Return on Assets - 5 Yr. Avg. | -- | 12.95 | 12.33 | |
| Return on Investment (TTM) | -60.80 | 14.89 | 14.48 | |
| Return on Investment - 5 Yr. Avg. | -- | 16.85 | 16.02 | |
| Return on Equity (TTM) | -61.05 | 16.01 | 15.78 | |
| Return on Equity - 5 Yr. Avg. | -- | 17.65 | 17.01 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -- | -- | -- |
| EPS (TTM) % | -- | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Kalvista Pharmaceuticals Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -12.01 | -15.05 | 11 | 24 |
| 13 Week | 1.40 | -3.54 | 60 | 40 |
| 26 Week | -3.33 | -10.68 | 48 | 41 |
| 52 Week | -4.10 | -18.72 | 43 | 10 |
| YTD | 2.55 | -9.94 | 47 | 38 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 88.83% |
| # of Holders: | 117 |
| Total Shares Held: | 15,825,648 |
| 3 Mo. Net Change: | 131,269 |
| # New Positions: | 9 |
| # Closed Positions: | 2 |
| # Increased Positions: | 15 |
| # Reduced Positions: | 5 |
| # Net Buyers: | 10 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.